News Industry News New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery November 14, 2017
News Industry News Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin August 25, 2016